Nano™ 2nd Gen Pen Needles are the only pen needles aligned to expert recommendations1*. Company Backgroundembecta is a global company that develops and provides solutions
Acquisition will position embecta to participate in the rapidly expanding market for drug-delivery devices supporting generic and branded therapies and accelerate transformation into a broad‑based
Nano™ 2nd Gen Pen Needles are the only pen needles aligned to expert recommendations1*. Company Backgroundembecta is a global company that develops and provides solutions
The Pharmacy500 is awarded to 500 supply chain businesses and associations that have made a significant impact on dispensing pharmacies in the U.S. over the
Cardinal Health RBC July 9-12, 2025 | Denver, CO The Cardinal Health Retail Business Conference (RBC) is an annual conference recognizing independent pharmacies and their
BD pen needles and insulin syringes are now part of embecta, a global diabetes care company. With this change, we are excited to introduce you
The Pharmacy500 is awarded to 500 supply chain businesses and associations that have made a significant impact on dispensing pharmacies in the U.S. over the
• While 9 out of 10 people with diabetes are living with T2D, many of the automated insulin delivery solutions currently on the market were
June 24, 2024 PARSIPPANY, N.J., June 24, 2024 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in
